Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Mitral Repair in Patients with Osteogenesis Imperfecta
Author(s): Merna Hassan , Yosef Manla , Nadya Almatrooshi , et al Added: 6 months ago

Intervention
Mitral and Tricuspid Transcatheter Edge-to-Edge Repair
Author(s): Jelena Z Arnautovic , Lina Ya’Qoub , Zarghoona Wajid , et al Added: 7 months ago

Demographic

Intervention
Mitral TEER – BCIS Position Statement
Author(s): Jonathan Byrne , Mamta Buch , Michael Mullen , et al Added: 2 months ago

Intervention
EuroPCR 25: The FATE Registry
Author(s): Fedrico de Marco Added: 1 month ago
EuroPCR 2025 - Outcomes from the FATE Registry show coapttion gaps are at the upper limit of treatability in this patient group using current tTEER devices.Dr Fedrico de Marco (Centro Cardiologico Monzino IRCCS, Milan, IT) joins us to discuss the management and outcomes from the FATE registry, which investigated 123 case of failed tricuspid transcatheter edge-to-edge repair (tTEER) with all… View more

Intervention
TCT 24: The CLASP IID 2-Year RCT and Registry Outcomes
Author(s): Firas Zahr Added: 7 months ago
TCT Conference 24 - Two-year outcomes of CLASP IID shows that the Edwards PASCAL system was noninferior to the Abbott Mitraclip system in transcatheter mitral valve repair for mitral regurgitation.Dr Firas Zahr (Oregon Health and Science University, US) joins us onsite at TCT Conference to discuss the outcomes from the CLASP IID 2 Year RCT and Registry (NCT02371512; Edwards Lifesciences).CLASP… View more

Intervention
TCT 24: The MATTERHORN Trial
Author(s): Stephan Baldus Added: 7 months ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,… View more

Heart Failure

Intervention
LINC 25: The PATCH Study
Author(s): Sean Lyden Added: 4 months ago
LINC Conference 2025 - 30 day results of the PATCH study suggests the PerQSeal vascular closure device (Vivasure Medical Limited) can be used as an alternative percutaneous procedure for large-bore common femoral access, showing low risk of haematoma and a medium time of 0 minutes to achieve vessel closure.Dr Sean Lyden (Cleveland Clinic, Cleveland, OH, US) joins us to discuss the PATCH single… View more

Vascular Disease and Surgery

Intervention
Job title: Director
Job title: Associate Professor
Joost van Herwaarden is a Full Professor in the Department of Vascular Surgery at the University Medical Center, Utrecht, the Netherlands. Prof van Herwaarden’s research interests included abdominal aortic aneurysms, endovascular repair, endovascular aneurysm repair and imaging modalities. With over seventy papers published in peer-reviewed journals, Prof van Herwaarden is a member of View more
Research Area(s) / Expertise:
Dr Gilbert Tang is Surgical Director of the Structural Heart Program at the Mount Sinai Health System and Professor of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai in New York. He has performed over 2000 cases of transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (MitraClip), transcatheter mitral valve replacement, and tricuspid valve repair… View more